donor lymphocyte infusions for post-transplant relapse of refractory anemia with excess blasts and monosomy 7

Pediatric Blood and Cancer

Volumn 50, Issue 3, 2008, Pages 670-672

  Skinner, R ^a,b   Velangi, M ^a   Bown, N ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Child; Donor lymphocyte infusion; MDS; Monosomy 7; RAEB; Relapse

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHIMERA; DETERIORATION; DONOR LYMPHOCYTE INFUSION; GRAFT VERSUS LEUKEMIA EFFECT; GRAFT VERSUS MYELODYSPLASIA; HLA MATCHING; HUMAN; MALE; MONOSOMY 7; MYELODYSPLASIA; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS; RELAPSE; SCHOOL CHILD; TREATMENT RESPONSE;

ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHROMOSOMES, HUMAN, PAIR 7; COMBINED MODALITY THERAPY; HUMANS; LYMPHOCYTE TRANSFUSION; MALE; MONOSOMY; RECURRENCE; REMISSION INDUCTION; TISSUE DONORS; TRANSPLANTATION CONDITIONING;

EID: 38549176166     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21146     Document Type: Article

References (13)

1. Passmore SJ, Chessells JM, Kempski H, et al. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: A population-based study of incidence and survival. Br J Haematol 2003;121:758-767.
2. Hasle H, Niemeyer CM, Chessells JM, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003;17:277-282.
3. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-2088.
4. Webb DKH, Passmore SJ, Hann IM, et al. Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99. Br J Haematol 2002;117:33-39.
5. Hasle H, Arico M, Basso G, et al. Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. Leukemia 1999; 13:376-385.
6. Woods WG, Barnard DR, Alonzo TA, et al. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodyspastic syndrome: A report from the Children's Cancer Group. J Clin Oncol 2002;20:434-440.
7. Bader P, Niemeyer CM, Willasch A, et al. Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy. Br J Haematol 2005;128:649-658.
8. Peggs KS, Mackinnon S. Cellular therapy: Donor lymphocyte infusion. Hematol 2001;8:349-354.
9. Matthes-Martin S, Mann G, Peters C, et al. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: A single centre experience and review of the literature. Bone Marrow Transplant 2000;26:377-382.
10. Worth A, Rao K, Webb D, et al. Successful treatment of juvenile myelomonocytic leukemia relapsing after stem cell transplantation using donor lymphocyte infusion. Blood 2003;101: 1713-1714.
11. Depil S, Deconinck E, Milpied N, et al. Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome. Bone Marrow Transplant 2004;33: 531-534.
12. Castagna L, El Wishi A, Bourhis JH, et al. Successful donor lymphocyte infusion (DLI) in a patient with myelodysplastic syndrome (MDS) after failure of T-cell-depleted bone marrow transplantation (TD-BMT). Br J Haematol 1998;103:284-285.
13. Shiobara S, Nakao S, Ueda M, et al. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: Lower incidence of acute graft-versus-host disease and improved outcome. Bone Marrow Transplant 2000;26:769-774.